Safety & Efficacy of a Fixed Dose Combination of Paracetamol (125 mg), Phenylephrine (2.5 mg) and Chlorpheniramine Maleate (1mg) [Flucold Drops] in the Treatment of Common Cold and Flu Syndrome in Children : Postmarketing Surveillance Study
dc.contributor.author | Kumar, Pankaj | en_US |
dc.contributor.author | Menezes, Rashmi | en_US |
dc.contributor.author | Pinto, Vinay | en_US |
dc.contributor.author | Arora, Deepak | en_US |
dc.contributor.author | Jayseela, Karunraj | en_US |
dc.contributor.author | Kumar, Sumit | en_US |
dc.contributor.author | Rajdeo, Dipeshh | en_US |
dc.contributor.author | S, Harish | en_US |
dc.contributor.author | Z, Vinda | en_US |
dc.contributor.author | D, Tapas | en_US |
dc.date.accessioned | 2023-06-17T08:33:54Z | |
dc.date.available | 2023-06-17T08:33:54Z | |
dc.date.issued | 2022-05 | |
dc.description.abstract | Background :The common cold and flu syndrome primarily affects the upper respiratory tract, along with a low fever and some systemic symptoms such as sore throat, cough, nasal decongestion, headache, and so on. Several clinical studies have shown that combining analgesics, antihistaminics, and decongestants provides better symptom relief in the common cold. The current post-marketing surveillance study was designed to look into the safety and efficacy of commercially available Flucold Drops in the Indian population. Methodology :A current prospective, single arm, multicenter, post-marketing clinical study included 224 subjects, 220 of whom completed the study. All patients were given Flucold Drops for three days and then monitored for the next six days. During the study, the incidence of adverse events (AE) and serious adverse events (SAE) was assessed. The efficacy of the Flucold Drops was evaluated using VAS score changes from the beginning to the end of the treatment. The product’s safety was also evaluated using blood biomarkers such as haemoglobin, platelet count, SGOT, SGPT, and creatinine level. Results : Results show the reduction in symptomatic score of common cold and flu syndrome observed after 2rd follow-up visit (0.202+0.325 to 0.139+0.231). During the study, no intervention-related adverse events were observed. Furthermore, no Serious Adverse Events (SAE) were observed in the study or follow-up period. The study found no changes in the levels of blood biomarkers (haemoglobin, platelets, SGOT, SGPT, and creatinine). Conclusions : Flucold Drops are safe and effective in the treatment of common cold and flu syndrome in Children and infants. | en_US |
dc.identifier.affiliations | Wallace Pharmaceutical Pvt Ltd | en_US |
dc.identifier.affiliations | ICBio Clinical Research Pvt Ltd, *Crossponding Autho | en_US |
dc.identifier.citation | Kumar Pankaj, Menezes Rashmi, Pinto Vinay, Arora Deepak, Jayseela Karunraj, Kumar Sumit, Rajdeo Dipeshh, S Harish, Z Vinda, D Tapas. Safety & Efficacy of a Fixed Dose Combination of Paracetamol (125 mg), Phenylephrine (2.5 mg) and Chlorpheniramine Maleate (1mg) [Flucold Drops] in the Treatment of Common Cold and Flu Syndrome in Children : Postmarketing Surveillance Study. Journal of The Indian Medical Association. 2022 May; 120(5): 75-79 | en_US |
dc.identifier.issn | 0019-5847 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/216544 | |
dc.language | en | en_US |
dc.publisher | Indian Medical Association | en_US |
dc.relation.issuenumber | 5 | en_US |
dc.relation.volume | 120 | en_US |
dc.source.uri | https://www.onlinejima.com/read_journals.php?article=951 | en_US |
dc.subject | Flucold Drops is a fixed dose combination of paracetamol (125 mg) | en_US |
dc.subject | phenylephrine (2.5 mg) and chlorpheniramine maleate (1mg) | en_US |
dc.subject | SGOT | en_US |
dc.subject | SGPT | en_US |
dc.subject | Flu syndrome | en_US |
dc.subject | Congestion | en_US |
dc.subject | Haemoglobin | en_US |
dc.title | Safety & Efficacy of a Fixed Dose Combination of Paracetamol (125 mg), Phenylephrine (2.5 mg) and Chlorpheniramine Maleate (1mg) [Flucold Drops] in the Treatment of Common Cold and Flu Syndrome in Children : Postmarketing Surveillance Study | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1